Hodgkin lymphoma-associated superior vena cava syndrome: A case report and review of the literature

Abstract

Patient: Male, 53-year-old Final Diagnosis: Hodgkin lymphoma • superior vena cava syndrome Symptoms: Dry cough • dyspnea • facial edema • fatigue Medication: — Clinical Procedure: — Specialty: Hematology • Oncology Objective: Background: Case Report: Conclusions: Rare co-existance of disease or pathology Hodgkin lymphoma (HL) is a relatively rare etiology of superior vena cava (SVC) syndrome, with only 24 cases reported in the literature. The characteristics, management, and prognosis of HL-associated SVC syndrome re-main unclear. This case report describes nodular sclerosis classical HL and the associated clinical manifestations presenting as SVC syndrome in a middle-aged patient, and it summarizes the characteristics of HL-associated SVC syndrome. In this case report, we present a 53-year-old Hispanic man with progressively worsening dyspnea, dry cough, facial and neck edema, and dysphagia. SVC syndrome was diagnosed, and pathology revealed nodular sclerosis classical HL. The patient was treated with doxorubicin, bleomycin, vinblastine, and dacarbazine. SVC syndrome improved, and repeated imaging showed that the lymphoma had decreased in size and had become metabolically inactive. We reviewed the characteristics, management, and prognosis of HL-associated SVC syndrome, which may in-dicate more advanced and recurrent progression in patients with HL. This possibility suggests that physicians should provide urgent diagnosis and closer follow-up, and more aggressive therapies may be needed because of the high risk of recurrence. Therapy may induce late-onset SVC syndrome in patients with HL.